Bacterial screening of platelet components by National Health Service Blood and Transplant, an effective risk reduction measure

Transfusion

Volumn 57, Issue 5, 2017, Pages 1122-1131

  McDonald, Carl ^a   Allen, Jennifer ^a   Brailsford, Susan ^a   Roy, Anjana ^a   Ball, Joanne ^a   Moule, Richard ^a   Vasconcelos, Mariza ^a   Morrison, Rachael ^a   Pitt, Tyrone ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGGREGATIBACTER APHROPHILUS; APHERESIS; ARTICLE; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BACTERIUM DETECTION; CLINICAL ARTICLE; CORYNEBACTERIUM PSEUDODIPHTHERITICUM; ENTEROCOCCUS FAECALIS; ERYTHROCYTE; ESCHERICHIA COLI; FALSE POSITIVE RESULT; GEMELLA HAEMOLYSANS; GEMELLA MORBILLORUM; GRANULICATELLA ADIACENS; HUMAN; KLEBSIELLA PNEUMONIAE; LACTOBACILLUS CASEI; LACTOBACILLUS DELBRUECKII SUBSP. LACTIS; LEUKOCYTE COUNT; LISTERIA MONOCYTOGENES; MICROORGANISM DETECTION; MORBIDITY; PARVIMONAS MICRA; PROPIONIBACTERIUM ACNES; RISK REDUCTION; SCREENING; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS ACIDOMINIMUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS CONSTELLATUS; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS EQUINUS; STREPTOCOCCUS INTERMEDIUS; STREPTOCOCCUS MITIS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS PARASANGUINIS; STREPTOCOCCUS SALIVARIUS; THROMBOCYTE; THROMBOCYTE COUNT; ADVERSE EFFECTS; BACTERIAL INFECTIONS; BLOOD BANK; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PROCEDURES; PUBLIC HEALTH; STANDARDS; THROMBOCYTE TRANSFUSION; THROMBOCYTOPHERESIS; TIME FACTOR; TRANSMISSION;

BACTERIAL INFECTIONS; BACTERIOLOGICAL TECHNIQUES; BLOOD BANKS; BLOOD PLATELETS; HUMANS; NATIONAL HEALTH PROGRAMS; PLATELET TRANSFUSION; PLATELETPHERESIS; RISK REDUCTION BEHAVIOR; STAPHYLOCOCCUS AUREUS; TIME FACTORS;

EID: 85018662245     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14085     Document Type: Article

References (44)

1. Borden CW, Hall WH. Fatal transfusion reactions from massive bacterial contamination of blood. N Engl J Med 1951;245:760-5.
2. Fatalities reported to FDA following blood collection and transfusion. Annual Summary for Fiscal Year 2009 [Internet]. Silver Spring (MD): Center for Biologics Evaluation and Research, Food and Drug Administration, U.S.Department of Health and Human Services; [cited 2013 Feb 04]. Available from: http://www.fda.gov/downloads/Biologics BloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/UCM205620.pdf.
3. Fatalities reported to FDA following blood collection and transfusion. Annual Summary for Fiscal Year 2014 [Internet]. Silver Spring (MD): Center for Biologics Evaluation and Research, Food and Drug Administration, U.S. Department of Health and Human Services; 2014 [cited 2016 Apr 14]. Available from: https://www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/UCM459461.pdf.
4. Standards for blood banks and transfusion services. 24th ed. AABB Standard 5.4.21. Bethesda (MD): AABB; 2006.
5. Bolton-Maggs P, Poles D. Annual SHOT report 2014. Manchester: SHOT Office; 2015.
6. McDonald C, McGuane S, Thomas J, et al. A novel rapid and effective donor arm disinfection method. Transfusion 2010;50:53-8.
7. Satake M, Mitani T, Oikawa S, et al. Frequency of bacterial contamination of platelet concentrates before and after introduction of diversion method in Japan. Transfusion 2009;49:2152-7.
8. McDonald CP, Roy A, Mahajan P, et al. Relative values of the interventions of diversion and improved donor-arm disinfection to reduce the bacterial risk from blood transfusion. Vox Sang 2004;86:178-82.
9. McDonald CP, Roy A, Lowe P, et al. Evaluation of the BacT/Alert automated blood culture system for detecting bacteria and measuring their growth kinetics in leucodepleted and non-leucodepleted platelet concentrates. Vox Sang 2001;81:154-60.
10. McDonald CP, Rogers A, Cox M, et al. Evaluation of the 3D BacT/ALERT automated culture system for the detection of microbial contamination of platelet concentrates. Transfus Med 2002;12:303-9.
11. Borosak M, Wood EM. Bacterial pre-release testing of platelets—the Australian Red Cross Blood Service clinical experience. Transfus Med Hemother 2011;38:239-41.
12. Curran D, Cadden E, Murphy WG. BacT alert false positives during platelet screening [abstract]. Transfusion 2012;52:200A.
13. Benjamin RJ, McDonald CP. The international experience of bacterial screen testing of platelet components with an automated microbial detection system: a need for consensus testing and reporting guidelines. Transfus Med Rev 2014;28:61-71.
14. Wagner SJ, Eder AF. A model to predict the improvement of automated blood culture bacterial detection by doubling platelet sample volume. Transfusion 2007;47:430-3.
15. Souza S, Bravo M, Poulin T, et al. Improving the performance of culture-based bacterial screening by increasing the sample volume from 4 mL to 8 mL in aerobic cultures. Transfusion 2012;52:1576-82.
16. Eder AF, Kennedy JM, Dy BA, et al. Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safety. Transfusion 2009;49:1554-63.
17. Tomasulo P, Wagner SJ. Predicting improvement in detection of bacteria in apheresis platelets by maintaining constant component sampling proportion. Transfusion 2013;53:835-42.
18. Koopman MM, van't Ende E, Lieshout-Krikke R, et al. Bacterial screening of platelet concentrates: results of 2 years active surveillance of transfused positive cultured units released as negative to date. Vox Sang 2009;97:355-7.
19. Murphy WG, Foley M, Doherty C, et al. Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Vox Sang 2008;95:13-9.
20. Schrezenmeier H, Walther-Wenke G, Müller TH, et al. Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets. Transfusion 2007;47:644-52.
21. Hsueh J, Ho C, Chang S, et al. Blood surveillance and detection on platelet bacterial contamination associated with septic events. Transfus Med 2009;19:350-6.
22. Ramirez-Arcos S, Kou Y, Perkins H. Evaluation of a universal point-of-issue assay for bacterial detection in buffy coat platelet components. Vox Sang 2014;107:192-5.
23. Heaton WA, Good CE, Galloway-Haskins R, et al. Evaluation of a rapid colorimetric assay for detection of bacterial contamination in apheresis and pooled random-donor platelet units. Transfusion 2014;54:1634-41.
24. Vollmer T, Schottstedt V, Bux J, et al. Bacterial screening of platelet concentrates on day 2 and 3 with flow cytometry: the optimal sampling time point? Blood Transfus 2014;12:388-95.
25. Munksgaard L, Albjerg L, Lillevang ST, et al. Detection of bacterial contamination of platelet components: six years’ experience with the BacT/ALERT system. Transfusion 2004;44:1166-73.
26. Pearce S, Rowe GP, Field SP. Screening of platelets for bacterial contamination at the Welsh Blood Service. Transfus Med 2011;21:25-32.
27. Fang CT, Chambers LA, Kennedy J, et al. Detection of bacterial contamination in apheresis platelet products: American Red Cross experience, 2004. Transfusion 2005;45:1845-52.
28. Macauley A, Chandrasekar A, Geddis G, et al. Operational feasibility of routine bacterial monitoring of platelets. Transfus Med 2003;13:189-95.
29. Ramírez-Arcos S, Jenkins C, Dion J, et al. Canadian experience with detection of bacterial contamination in apheresis platelets. Transfusion 2007;47:421-9.
30. Larsen CP, Ezligini F, Hermansen NO, et al. Six years’ experience of using the BacT/ALERT system to screen all platelet concentrates, and additional testing of outdated platelet concentrates to estimate the frequency of false-negative results. Vox Sang 2005;88:93-7.
31. Achermann Y, Goldstein EJ, Coenye T, et al. Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen. Clin Microbiol Rev 2014;27:419-40.
32. Rood IG, de Korte D, Ramirez-Arcos S, et al. Distribution, origin and contamination risk of coagulase-negative staphylococci from platelet concentrates. J Med Microbiol 2011;60:592-9.
33. Jaipian J, Chuansumrit A, Chonkolwatana V, et al. Collection efficacies of double dose platelet by blood separators. J Haematol Transfus Med 2013;23:121-7.
34. Jacobs MR, Good CE, Lazarus HM, et al. Relationship between bacterial load, species virulence, and transfusion reaction with transfusion of bacterially contaminated platelets. Clin Infect Dis 2008;46:1214-20.
35. McDonald C. Bacterial testing of platelet components: is there added benefit for our donors? Transfusion 2013;53:2117-9.
36. Lee CK, Chan HM, Ho PL, et al. Long-term clinical outcomes after Streptococcus bovis isolation in asymptomatic blood donors in Hong Kong. Transfusion 2013;53:2207-10.
37. Hong H, Xiao W, Lazarus HM, et al. Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance. Blood 2016;127:496-502.
38. Parry MA, Zhang XC, Bode I. Molecular mechanisms of plasminogen activation: bacterial cofactors provide clues. Trends Biochem Sci 2000;25:53-9.
39. Jenkins C, Ramírez-Arcos S, Goldman M, et al. Bacterial contamination in platelets: incremental improvements drive down but do not eliminate risk. Transfusion 2011;51:2555-65.
40. Eder AF, Kennedy JM, Dy BA, et al. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Transfusion 2007;47:1134-42.
41. de Korte D. 10 years experience with bacterial screening of platelet concentrates in the Netherlands. Transfus Med Hemother 2011;38:251-4.
42. Dumont LJ, Kleinman S, Murphy JR, et al. Screening of single-donor apheresis platelets for bacterial contamination: the PASSPORT study results. Transfusion 2010;50:589-99.
43. Bruneau C, Perez P, Chassaigne M, et al. Efficacy of a new collection procedure for preventing bacterial contamination of whole-blood donations. Transfusion 2001;41:74-81.
44. Goodhand K, Simonds L, McGuane S, et al. Assessment of interventions aimed at reducing the bacterial contamination rate of platelet concentrates [abstract]. Transfus Med 2008;18(Suppl 2):40(P28).